In the past 10 years, Thermo Fisher Pharma Services has received more NDA approvals than the next 3 CDMO’s combined.
Partner with Thermo Fisher Scientific and benefit from our depth and breadth of experience, reliability of quality and refinement of processes—all of which are vital in the final push for regulatory approval and in making the transition to commercial manufacturing.
With industry-leading depth of expertise and resources, responsiveness, flexibility, and dependable quality, Thermo Fisher Scientific teams understand the approval process inside and out. We can work with you to achieve parallel active pharmaceutical ingredient (API) and finished dose development—delivering on time and Right-The-First-Time.
Our seasoned experts know exactly what’s required and the pitfalls that lead to costly delays. We consistently deliver high quality in everything we do, and this has earned us the trust of the world’s top 20 pharmaceutical companies, and 17 of the top 20 biotech companies.
Where some may view regulatory inspections as a hurdle, we view them as an impartial measure of excellence. Over 85 regulatory authorities have inspected and approved our operations over the past five years.
Last year alone, we manufactured more than 700 large and small molecule products, approved for more than 70 countries. But success isn’t just about scale, it also reflects our ability to deliver exceptional quality and service. In 2008, 2010, 2011 and 2012 we were recognized with the European Outsourcing Award for Most Effective Scale-up and Technology Transfer.
Looking for a partner for a commercial pharmaceutical manufacturing project?